Avalon GloboCare Corp. Material Event - What Happened

Here is the latest news on Avalon GloboCare Corp. (ticker: ALBT). We have removed the complex financial jargon to help you understand what is happening and why it matters for your investment.

1. What happened?

Avalon GloboCare Corp. (Nasdaq: ALBT) received a warning from the Nasdaq. Its stock price has fallen below the $1.00 minimum required to stay on the exchange. Because of this, the company is currently not meeting Nasdaq’s rules for continued listing.

2. When did it happen?

Nasdaq officially notified the company on April 15, 2026, after the stock price remained below the $1.00 threshold for 30 consecutive business days.

3. Why does this matter?

Being on the Nasdaq provides liquidity, meaning it is easier for you to buy and sell shares. If a stock is forced off the exchange and onto the "Over-the-Counter" (OTC) market, it often becomes harder to trade. Furthermore, many large institutional investors are prohibited from holding stocks that aren't on major exchanges, which can lead to selling pressure. It also makes it more difficult and expensive for the company to raise the capital needed to fund its research.

4. Who is affected?

• Investors: You may see increased price volatility. The company might choose to perform a "reverse stock split" to artificially boost the share price. For example, in a 1-for-10 split, you would have fewer shares, but each share would be worth ten times more. While your total investment value remains the same, the market often views these moves as a sign of financial distress.
• The Company: Management must now divert time and resources toward regaining compliance rather than focusing entirely on their clinical trials and business growth.
• Traders: The stock may attract speculators. Some traders bet against companies in this position, which can create downward pressure on the share price.

5. What happens next?

Avalon has until October 12, 2026, to fix this. To regain compliance, their stock price must close at $1.00 or higher for at least 10 consecutive business days. If they fail to meet this deadline, they may be eligible for an additional 180-day grace period, provided they meet other financial requirements.

6. What should you look for?

• Don't panic: This notice is a standard regulatory procedure, not an immediate removal from the exchange. The stock continues to trade normally as "ALBT."
• Watch for "Reverse Splits": If the company announces a reverse split, remember that it is a mathematical adjustment. It does not improve the company’s underlying business, cash flow, or clinical trial results.
• Focus on the fundamentals: Keep an eye on the company’s official filings for a "plan to regain compliance." The most sustainable way for the stock to recover is through positive news regarding their clinical trials or new funding, which can naturally drive investor interest and the share price back above $1.00.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and does not constitute financial advice. Always do your own research and consult with a professional before making investment decisions.